High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19

The presence of anti-IFN neutralizing antibodies (NAB) has been reported in critically ill COVID-19 patients. We found that 87.5% (7/8) of HIV-1 patients co-infected with SARS-CoV-2 had serum anti-IFN-I NAB against IFN-α subtypes, IFN-β and/or IFN-ω. Anti-IFN-I NAB were also detected in oropharyngea...

Descripción completa

Detalles Bibliográficos
Autores principales: Scordio, Mirko, Frasca, Federica, Santinelli, Letizia, Sorrentino, Leonardo, Pierangeli, Alessandra, Turriziani, Ombretta, Mastroianni, Claudio M., Antonelli, Guido, Viscidi, Raphael P., d'Ettorre, Gabriella, Scagnolari, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233547/
https://www.ncbi.nlm.nih.gov/pubmed/35764258
http://dx.doi.org/10.1016/j.clim.2022.109068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233547/
https://www.ncbi.nlm.nih.gov/pubmed/35764258
http://dx.doi.org/10.1016/j.clim.2022.109068

Ejemplares similares